| Title： | Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021) |
| Edition： | Adapted |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians, health decision makers, and relevant research staff working on pediatric diseases in all levels of hospitals are the population to use this guideline. |
| Evidence classification method： | GRADE |
| Development unit： | Beijing Children′s Hospital |
| Registration time: | 2024-04-08 |
| Registration number： | IPGRP-2020CN077 |
| Purpose of the guideline: | The purpose of this guideline is to provide an evidence-based basis for the clinical diagnosis and treatment of ITP in Chinese children, to standardize the clinical diagnosis and treatment decisions of ITP in Chinese children, and to provide evidence-based support for clinical practice. |
